Vital Signs Monitoring Devices Market By Product (Multiparameter Patient Monitors, Blood Pressure Monitoring Devices, Pulse Oximeters, Temperature Monitoring Devices, Heart-Rate and Respiratory-Rate Monitors, Wearable and Remote Vital Signs Monitoring Devices, Accessories and Consumables); By Application (Hypertension and Cardiovascular Monitoring, Respiratory and Oxygen-Saturation Monitoring, Emergency and Critical-Care Monitoring, Perioperative and Postoperative Monitoring, General Ward and Patient-Deterioration Monitoring, Remote Patient and Chronic-Disease Monitoring, Dialysis and Recurring Therapy Monitoring, Neonatal and Pediatric Monitoring); By End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Physician Offices, Diagnostic Centers, Home-Care Settings, Emergency Medical Services, Long-Term Care and Rehabilitation Facilities, Dialysis Centers); By Geography, Segment Revenue Estimation and Forecast, 2026–2032

Vital Signs Monitoring Devices Market: Connected Care, Hospital Modernization, and Home Monitoring Expansion

The Global Vital Signs Monitoring Devices Market was valued at USD 7.56 billion in 2025 and is projected to reach USD 15.76 billion by 2032, growing at a CAGR of 9.6%, according to Strategic Market Research. The market is shifting from isolated measurement equipment toward connected monitoring systems that follow patients across hospitals, clinics, ambulatory facilities, transport settings, and homes. The category includes blood pressure monitors, pulse oximeters, thermometers, heart-rate and respiratory-rate monitors, multiparameter bedside systems, wearable devices, central monitoring stations, software, and reusable or disposable accessories.

 

Demand cannot be linked to one disease group. Vital signs monitoring is used in hypertension care, respiratory treatment, emergency settings, surgery, intensive care, dialysis, post-discharge follow-up, and routine assessment. Patient groups often overlap. Combining hypertension, COPD, sepsis, surgical, and dialysis populations would therefore overstate the addressable market. A more practical approach separates home-device sales, hospital equipment, monitored encounters, and recurring sensor or accessory revenue.

 

The segment shares and revenues in this analysis are internal Strategic Market Research estimates based on a USD 7.56 billion market in 2025. The estimates reflect healthcare utilization, installed equipment, device pricing, purchasing behavior, manufacturer activity, and accessory demand.

 

Market growth is shifting beyond standalone hardware. Hospitals now place greater value on electronic medical record connectivity, central surveillance, software updates, and compatibility across care settings. Home-monitoring suppliers are also moving toward connected devices and clinician-facing services instead of depending mainly on one-time consumer sales.

 

Hypertension Creates the Broadest Volume Opportunity

Blood pressure monitoring has the largest clearly quantified disease-related user base in the market. Nearly 119.9 million U.S. adults, or 48.1% of the adult population, have hypertension under the U.S. definition of blood pressure at or above 130/80 mm Hg or current antihypertensive medication use. The size of the uncontrolled population sustains repeated measurement across primary-care clinics, pharmacies, community programs, and homes.

Globally, approximately 1.4 billion adults aged 30–79 lived with hypertension in 2024, while only slightly more than one in five had the condition under control. The large undiagnosed and uncontrolled population supports continued investment in affordable and clinically validated blood pressure monitoring.

Blood pressure monitoring devices accounted for approximately 27.8% of the total market in 2025, equivalent to nearly USD 2.10 billion. The segment is projected to expand at an estimated 8.2% CAGR through 2032. Its growth rate is below that of medical wearables because conventional blood pressure monitoring is already widely established, but the segment retains a large revenue base through home-device replacement, connected applications, physician-led remote monitoring, and institutional purchases.

OMRON reports more than 400 million cumulative home-use blood pressure monitors sold worldwide. The figure represents one manufacturer’s cumulative sales rather than annual category shipments, but it demonstrates the physical scale of home blood pressure monitoring relative to higher-priced hospital systems.

 

Acute-Care Utilization Supports Higher-Value Hospital Systems

Home blood pressure monitors may account for greater physical unit volumes, but hospitals generate considerably more revenue per monitoring system. Purchases may include bedside monitors, transport units, telemetry, central stations, software, network integration, service agreements, replacement modules, cables, probes, cuffs, and single-patient accessories.

The United States recorded 155.4 million emergency department visits in 2022. Of these, 17.8 million resulted in hospital admission, while 3.1 million led to critical-care admission. These figures represent encounters rather than unique patients, but they illustrate the number of care episodes requiring initial and repeated physiological assessment.

Surgery provides another substantial utilization pathway. The AHRQ Nationwide Ambulatory Surgery Sample covered 13.5 million in-scope ambulatory surgery encounters in 2023, an increase of 9% from 12.4 million in 2022. Separate AHRQ evidence identified 14.4 million operating-room procedures during 9.6 million inpatient stays in 2018. The datasets cover different years and settings, but both support recurring demand for preoperative, intraoperative, recovery, and postoperative monitoring.

Hospital procurement is moving toward platforms that can remain with patients across emergency departments, operating rooms, recovery areas, intensive-care units, general wards, and internal transport. Suppliers offering compatible monitors across several acuity levels are better positioned for hospital-wide standardization contracts.

 

Respiratory Burden Sustains Pulse Oximetry Demand

Pulse oximetry remains commercially relevant across respiratory disease, anesthesia, emergency care, intensive care, neonatal care, opioid surveillance, and oxygen therapy. Diagnosed COPD affected 3.8% of U.S. adults in 2023, while the disease caused 141,733 U.S. deaths that year. Globally, COPD caused approximately 3.4 million deaths in 2023.

Pulse oximeters and dedicated oxygen-saturation monitoring products generated approximately USD 1.16 billion in 2025, representing 15.4% of the global market. The segment is projected to grow at an estimated 9.0% CAGR through 2032, supported by hospital monitoring, respiratory care, home oxygen pathways, perioperative use, and the inclusion of pulse oximetry in wearable and multiparameter systems.

COPD prevalence does not translate directly into continuous device use. Utilization rises when patients experience exacerbations, receive oxygen, enter emergency care, undergo rehabilitation, or require hospitalization. Revenue therefore depends more on monitoring frequency and care intensity than on total disease prevalence.

Regulatory expectations may also shift purchasing toward clinically validated products. FDA’s January 2025 draft guidance proposed broader testing of medical pulse oximeters following concerns that performance can vary with skin pigmentation and other patient factors. Stronger validation requirements may increase development costs while widening the distinction between regulated medical devices and inexpensive general-wellness products.

 

Sepsis and Patient Deterioration Expand Continuous Surveillance

Sepsis, acute respiratory decline, postoperative complications, and medication-related respiratory depression create demand for monitoring that can identify deterioration between scheduled nursing observations. The supplied evidence identifies at least 1.7 million adult sepsis hospitalizations and 350,000 sepsis-associated deaths annually in the United States. Vital signs monitors do not independently diagnose or treat sepsis, but changes in temperature, blood pressure, heart rate, oxygen saturation, and respiratory rate contribute to escalation decisions.

Hospitals are consequently extending continuous or frequent monitoring beyond intensive-care units. General wards contain larger patient populations but operate with different staffing and equipment budgets. Wearable monitors, wireless sensors, portable devices, and centralized surveillance systems allow providers to cover selected patients without placing a conventional high-acuity bedside monitor in every room.

In June 2026, Medtronic expanded its U.S. portfolio through a distribution agreement for an FDA-cleared Corsano multiparameter wearable. The product targets emergency, preoperative, medical-surgical, and cardiac-care environments, reflecting supplier interest in continuous monitoring outside traditional critical-care departments.

 

Remote Monitoring Connects Device Sales with Healthcare Services

Remote patient monitoring is widening the category beyond hospital equipment. Connected blood pressure monitors, pulse oximeters, thermometers, weight scales, and medical wearables can transmit physiological information for chronic-disease management, post-discharge surveillance, and shorter monitoring programs.

Wearable and remote vital-sign monitoring devices accounted for 12.6% of market revenue in 2025, equivalent to approximately USD 0.95 billion. With an estimated 15.7% CAGR through 2032, it is projected to be the fastest-growing product segment. Its expansion is supported by lower-acuity ward monitoring, hospital-at-home programs, remote chronic-care services, and demand for devices that measure several physiological parameters continuously.

Medicare recognizes remote patient monitoring in which connected medical devices automatically transmit health information such as blood pressure to a healthcare provider. The 2026 Medicare Physician Fee Schedule also updated rate-setting inputs for certain remote-monitoring services, giving providers a clearer commercial route for using connected devices within funded clinical workflows.

Successful remote-monitoring suppliers must address device connectivity, patient onboarding, data review, clinical documentation, and escalation. Hardware providers that cannot support these requirements risk competing primarily on price, while companies offering software, clinician dashboards, electronic-record connectivity, and service partnerships can capture more revenue from the monitoring workflow.

 

Dialysis Provides Predictable Recurring Utilization

Dialysis has a smaller patient population than hypertension but creates substantially more monitoring events per patient. Approximately 557,000 U.S. adults received maintenance dialysis in 2023. Blood pressure, pulse, temperature, weight, and clinical status are repeatedly assessed around treatment sessions, supporting dependable utilization of devices, cuffs, sensors, and related accessories.

The opportunity is concentrated in dialysis centers, hospital renal units, home-dialysis programs, and integrated kidney-care providers. Monitoring demand should be evaluated through treatment frequency and facility infrastructure rather than added to hypertension or cardiovascular patient totals, as the same patient may appear in several disease datasets.

 

Product and End-User Segmentation

Blood Pressure Monitoring Devices

Blood pressure monitors represented an estimated 27.8% share and USD 2.10 billion in 2025 revenue. They remain the largest product segment by physical unit volume because of the hypertension population, relatively low device cost, home suitability, and routine use across healthcare settings. The segment’s estimated 8.2% CAGR will be supported by replacement purchases, connected records, irregular-heartbeat screening, and remote hypertension-management services.

 

Multiparameter Patient Monitors

Multiparameter patient monitors formed the largest product category by revenue, with an estimated 35.0% market share in 2025, equal to approximately USD 2.65 billion. The segment is projected to grow at an estimated 9.5% CAGR through 2032.

Revenue also comes from software, accessories, maintenance and replacement. Hospital buyers increasingly prefer scalable platforms that support critical care, surgery and general wards through one network.

 

Pulse Oximeters and Respiratory Monitoring

Pulse oximeters accounted for an estimated 15.4% share and USD 1.16 billion in 2025 revenue. The estimated 9.0% CAGR reflects sustained respiratory, surgical, neonatal, emergency, and hospital surveillance demand. Medical-grade products face more demanding accuracy and validation expectations, while lower-priced retail products continue to create competition in basic home monitoring.

 

Wearable and Remote Monitoring Devices

Wearable and remote monitoring devices represented an estimated 12.6% share and USD 0.95 billion in 2025 revenue. Their projected 15.7% CAGR is the highest among the major product segments. Adoption depends on signal reliability, patient comfort, battery performance, workflow integration, reimbursement, and the ability to turn continuous data into clinically manageable alerts.

Thermometers, standalone heart-rate and respiratory devices, and other monitoring products collectively accounted for the remaining estimated 9.2% share, or approximately USD 0.70 billion, and are projected to grow at around 7.5% annually.

 

Hospitals and Ambulatory Facilities

Hospitals generated an estimated 55.7% of market revenue in 2025, equivalent to approximately USD 4.21 billion, and are projected to grow at a 9.1% CAGR. Their revenue leadership reflects the cost of multiparameter systems, central surveillance, software, network integration, maintenance, and recurring accessories.

Ambulatory surgery centers, physician clinics, diagnostic facilities, and other outpatient providers represented an estimated 18.5% share, or USD 1.40 billion, with an anticipated 8.7% CAGR. Demand is supported by the movement of procedures outside inpatient hospitals and the need for appropriately priced monitoring systems in smaller facilities.

 

Home-Care Users

Home care accounted for approximately 25.8% of 2025 revenue, equal to nearly USD 1.95 billion. The segment is projected to expand at an estimated 11.4% CAGR, faster than institutional hospital demand.

Blood pressure monitors form the largest established home category, while connected pulse oximeters and multiparameter wearables remain more selective. Growth depends on reimbursement, provider participation, patient adherence, device affordability, and whether monitoring information results in timely clinical action.

 

Accuracy, Interoperability, and Alarm Management Shape Purchasing

Hospitals no longer evaluate monitoring systems only through individual measurement specifications. Procurement decisions increasingly include electronic medical record compatibility, cybersecurity, software support, alarm configuration, accessory standardization, cleaning requirements, service coverage, and the cost of replacing an installed device network.

Alarm burden has become a competitive concern because greater continuous monitoring can increase the number of alerts presented to clinical teams. Philips reports more than one million IntelliVue monitors sold or in use and has introduced revised monitoring sounds intended to reduce alarm noise and improve recognition. Software changes across a large installed base can create commercial value without requiring immediate hardware replacement.

Data ownership and interoperability also influence supplier selection. Vendors that securely transfer information between bedside devices, central stations, mobile applications, and electronic records are better positioned for enterprise contracts than suppliers offering disconnected devices.

 

Competitive Landscape and Recent Market Activity

The market includes diversified hospital-equipment companies, specialist monitoring suppliers, home blood pressure brands, sensor manufacturers, and wearable-device developers. Major participants include Philips, GE HealthCare, Baxter, OMRON Healthcare, Nihon Kohden, Danaher/Masimo, and Medtronic. Comparable public company-level market shares are unavailable because manufacturers report different product categories, installed bases, revenues, and patient-use measures.

Philips launched its IntelliVue Patient Monitor 6000 Series in the United States in June 2026, targeting rural hospitals, ambulatory surgery centers, and other budget-sensitive facilities. Compatibility with established IntelliVue modules and supplies can reduce expansion costs for existing customers.

Baxter introduced the Welch Allyn Connex 360 Vital Signs Monitor in September 2025. The system transfers vital-sign information into electronic medical records through Baxter’s DeviceBridge platform, positioning connectivity and cybersecurity as central purchasing considerations.

GE HealthCare announced its Carevance platform in October 2025. The scalable system covers emergency, intensive-care, transport, and operating-room settings, supporting the broader move toward monitoring platforms that can follow patients through several departments.

Danaher completed its acquisition of Masimo in June 2026, adding pulse oximetry, patient-monitoring systems, sensors, and connectivity solutions to its Diagnostics segment. Masimo estimates that its SET technology monitors more than 200 million patients annually, although this patient-use figure is not directly comparable with device shipments or market revenue.

Medtronic and GE HealthCare expanded their global strategic alliance in March 2026, demonstrating the importance of partnerships where hospitals seek integrated monitoring, anesthesia, respiratory, and clinical-data capabilities.

 

Regional Market Direction

North America held an estimated 40.2% share of the global market in 2025, representing approximately USD 3.04 billion, and is projected to expand at an 8.8% CAGR. Its leadership is supported by hospital monitoring infrastructure, emergency and surgical utilization, established replacement cycles, and reimbursement for remote physiological monitoring.

Europe accounted for an estimated 27.9% share, or approximately USD 2.11 billion, with a projected 9.0% CAGR. Demand is shaped by hospital replacement programs, CE-marked product introductions, data-protection requirements, and migration toward modular monitoring platforms.

Asia-Pacific represented an estimated 24.8% share and USD 1.87 billion in 2025 revenue. It is projected to grow at approximately 11.5% annually, making it the fastest-growing regional market. Expansion is supported by hospital investment, hypertension screening, wider access to home monitoring, local manufacturing, and growing demand for lower-cost validated devices.

Latin America and the Middle East and Africa collectively accounted for the remaining estimated 7.1%, or approximately USD 0.54 billion, with an anticipated 10.4% CAGR. Adoption remains uneven and depends on public healthcare budgets, hospital infrastructure, distribution coverage, and device affordability.

 

Market Outlook

The vital signs monitoring devices market will remain divided between high-volume home measurement products and higher-value connected hospital platforms. Blood pressure monitoring provides the broadest unit opportunity, while multiparameter systems, software, service contracts, medical wearables, and recurring sensors generate greater revenue per customer.

Competitive advantage will depend on clinical accuracy, regulatory evidence, interoperability, cybersecurity, alarm management, service coverage, and installed-base compatibility. Revenue growth will increasingly come from replacing fragmented monitoring equipment, extending surveillance into general wards and ambulatory facilities, and connecting home devices with reimbursed clinical services.

 

Report Coverage Table

Report Attribute	Details
Forecast Period	2026 – 2032
Market Size Value in 2025	USD 7.56 Billion
Revenue Forecast in 2032	USD 15.76 Billion
Overall Growth Rate	CAGR of 9.6% (2026 – 2032)
Base Year for Estimation	2025
Historical Data	2019 – 2024
Unit	USD Million, CAGR (2026 – 2032)
Segmentation	By Product, By Application, By End User, By Geography
By Product	Multiparameter Patient Monitors (Bedside Monitors, Transport Monitors, Central Monitoring Systems); Blood Pressure Monitoring Devices (Digital Blood Pressure Monitors, Ambulatory Blood Pressure Monitors, Aneroid Blood Pressure Monitors); Pulse Oximeters (Fingertip Pulse Oximeters, Handheld Pulse Oximeters, Tabletop Pulse Oximeters); Temperature Monitoring Devices (Digital Thermometers, Infrared Thermometers, Continuous Temperature Monitors); Heart-Rate and Respiratory-Rate Monitors; Wearable and Remote Vital Signs Monitoring Devices; Accessories and Consumables (Cuffs, Sensors and Probes, Cables and Electrodes)
By Application	Hypertension and Cardiovascular Monitoring, Respiratory and Oxygen-Saturation Monitoring, Emergency and Critical-Care Monitoring, Perioperative and Postoperative Monitoring, General Ward and Patient-Deterioration Monitoring, Remote Patient and Chronic-Disease Monitoring, Dialysis and Recurring Therapy Monitoring, Neonatal and Pediatric Monitoring
By End User	Hospitals, Ambulatory Surgery and Patient-Deterioration Monitoring, Remote Patient and Chronic-Disease Monitoring, Dialysis and Recurring Therapy Monitoring, Neon Centers, Specialty Clinics and Physician Offices, Diagnostic Centers, Home-Care Settings, Emergency Medical Services, Long-Term Care and Rehabilitation Facilities, Dialysis Centers
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Country Scope	U.S., Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, South Korea, Australia, Brazil, Argentina, Saudi Arabia, United Arab Emirates, South Africa
Market Drivers	Rising demand for continuous and non-invasive patient monitoring, wider use of wearable and remote monitoring devices, growing prevalence of cardiovascular and respiratory conditions, stronger hospital focus on early patient-deterioration detection, and expansion of home-based chronic-disease management
Customization Option	Available upon request